Corvus: Q2 Earnings Snapshot

August 8, 2022 GMT

BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Monday reported a loss of $8.4 million in its second quarter.

The Burlingame, California-based company said it had a loss of 18 cents per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CRVS at